Acciones Isodiol International Inc Canadian Securities Exchange
Acciones
CA46500L1013
Farmacéuticos
Ventas 2018 | 19,14 M 26,04 M 17,68 M | Ventas 2019 | 22,25 M 30,27 M 20,55 M | Capitalización | 49,96 M 67,97 M 46,14 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -36 M -48,98 M -33,25 M | Resultado Neto 2019 | -126 M -171 M -116 M | VE / Ventas 2018 | 12,6 x |
Posición de caja neta 2018 | 15,55 M 21,16 M 14,36 M | Deuda neta 2019 | 5,22 M 7,1 M 4,82 M | VE / Ventas 2019 | 2,48 x |
P/E ratio 2018 |
-4,94
x | P/E ratio 2019 |
-0,37
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+22,67 % | 5358,87 M | |
-35,93 % | 3396,42 M | |
-6,69 % | 2902,48 M | |
-27,73 % | 2527,49 M | |
-11,46 % | 2269,26 M | |
+38,57 % | 1839,11 M | |
+38,46 % | 1423,94 M | |
-16,41 % | 1370,96 M | |
+42,86 % | 1377,83 M |